Trump’s AI Accord: Can Voluntary Self-Regulation and Independent Audits Protect Against Frontier AI Risks?

On September 29, President Trump brought together many of the leading executives in artificial intelligence for a White House meeting focused on the risks associated with increasingly powerful “frontier” AI systems. The meeting produced a one-page document entitled the “White House Accord on Super Intelligence, Joint Commitment on Frontier Responsibilities.”

The accord was signed by Trump and executives from Anthropic, Google, Meta, OpenAI, Nvidia, and xAI. It establishes what the participants describe as a four-layer system of controls and audits designed to make sure that frontier AI systems operate as intended and that safety problems are identified and addressed.

The agreement is noteworthy not because it creates a new legal requirement, it does not, but because it represents a significant endorsement by some of the world’s largest technology companies of a familiar regulatory concept: companies should establish internal controls, subject those controls to independent testing, and have their boards oversee the process.

The most important point about the agreement is that it is voluntary.

Although Trump described the agreement as “morally binding,” the document is not legally binding, does not create a federal regulatory requirement, impose penalties, designate a federal agency to supervise compliance, or establish a government certification process. The agreement itself describes the measures as commitments of the participating companies.

The accord states that every company developing and deploying frontier models should have “robust internal processes and controls” designed to ensure that its technology behaves as intended and that problems are promptly identified and resolved.

It then describes four layers of controls and audits as follows:

First, companies should implement internal controls to monitor the capabilities and alignment of their models during training and deployment. The accord specifically identifies cybersecurity, biosecurity, chemical threats, and the possibility that models could hack or access technical systems in unintended ways.

Second, each company should have an internal team responsible for determining whether those controls are operating as intended and whether identified problems are being remediated.

Third, and perhaps most interesting from a regulatory perspective, the company should partner with an independent external auditor or evaluator to assess whether the controls, monitoring, and detection mechanisms actually are operating as intended.

Finally, the company should designate an independent committee of its board of directors to oversee the reports of the internal and external auditors and ensure that identified problems are addressed.

The companies also agree to meet regularly to develop standards and best practices for improving the safety of their systems.

The commitment to independent external evaluation deserves particular attention.

The accord does not attempt to establish detailed technical standards governing what an auditor must test. Nor does it identify the auditors who will perform the work. Those questions remain unresolved.

Nevertheless, the concept is familiar in other highly regulated industries.

Financial institutions, public companies, manufacturers, healthcare companies, and other businesses routinely rely on independent testing and auditing as part of their risk-management systems. The underlying principle is straightforward: management should not be the only party determining whether management’s controls are working.

That principle becomes particularly important with frontier AI because the companies developing these systems possess technical knowledge that regulators and outsiders may not have. A regulatory framework that attempts to prescribe every technical safeguard could quickly become obsolete as the technology changes.

Independent assessment offers a potentially different model. Rather than having government prescribe every technological detail, companies could be required to demonstrate that they have effective controls and that qualified independent parties have tested those controls.

The accord therefore raises an important question: Could independent auditing become an effective middle ground between unrestricted self-regulation and detailed government regulation?

The answer to that question will depend heavily on how the concept develops.

The accord does not specify who qualifies as an independent auditor. It does not establish auditor qualifications, independence standards, testing methodologies, reporting requirements, or requirements concerning public disclosure of audit results. Nor does it say that the government will select or approve auditors. Those omissions are understandable in a short voluntary agreement, but they also identify the principal weakness of the framework.

An external evaluator hired and paid by the company being evaluated is obviously different from an auditor appointed by a government agency or another independent body. That does not mean a company-selected auditor cannot perform a meaningful review. It does mean that the credibility of the system will depend on the safeguards surrounding the auditor’s independence and the scope of the audit.

The accord also does not require publication of the audit reports. Consequently, the public may ultimately have to rely on representations by the AI companies concerning whether their systems have passed independent evaluations. That may be sufficient for some purposes. It may not be sufficient for others.

The fourth layer, independent board oversight, is also worth watching.

The agreement calls for an independent board committee to receive reports from both the internal team and external auditors and evaluators and to ensure that identified problems are remediated. This moves AI safety beyond the technology department and into the corporate-governance structure. That is potentially significant because the most difficult AI safety questions may involve competing corporate objectives. A company may have enormous financial incentives to deploy a new model quickly, even when testing identifies unresolved risks.

Requiring an independent board committee to receive the audit results creates a mechanism through which those risks can be elevated to directors who have responsibility for overseeing management. Again, however, the agreement does not prescribe how the committee should operate or what it must do when an auditor identifies a serious problem.

The most interesting sentence in the accord may be the one near the end: “Over time, it may make sense to codify these steps into laws or regulations.” That sentence leaves open an important possibility. The agreement could become a starting point for legislation or regulation rather than an alternative to it.

Congress could ultimately decide that frontier AI companies should be required to maintain specified internal controls, conduct independent assessments, and provide those assessments to an independent board committee. Regulators could then establish minimum standards concerning auditor independence, testing methodologies, reporting, confidentiality, and remediation.

That would produce a regulatory framework that is considerably different from simply prescribing detailed technical requirements for every AI system. The government would establish the governance framework while allowing the technology companies and independent evaluators to determine many of the technical details.

There is also a broader lesson here for regulators confronting rapidly changing technology.

The accord essentially adopts a familiar risk-management architecture:

Management controls → internal testing → independent testing → board oversight.

As stated above, that architecture is hardly unique to AI. Variations of it are already embedded in numerous corporate compliance and risk-management regimes. The challenge is determining whether the model can work when the underlying technology is changing at extraordinary speed.

There is a legitimate argument that government regulation should establish minimum governance and accountability requirements while leaving companies flexibility to determine how best to satisfy them. A requirement to have effective controls and independent testing may age considerably better than a regulation specifying exactly how an AI model must be constructed.

At the same time, voluntary commitments have an obvious limitation: there is no legal consequence for failing to comply. The significance of the Trump accord therefore may depend less on what it does today than on what happens next.

Will the participating companies actually implement meaningful independent audits? Will auditors have sufficient access and independence to identify serious problems? Will boards act on negative findings? Will audit results be made available to regulators or the public? And, perhaps most importantly, will Congress or federal regulators eventually convert some portion of these voluntary commitments into enforceable requirements?

Those questions remain unanswered.

For now, the accord represents an unusual experiment in technology governance: the leading developers of frontier AI have voluntarily embraced a framework that places internal controls, independent external assessment, and board oversight at the center of AI safety.

Whether that experiment can provide meaningful protection without becoming a legally enforceable regime remains to be seen.

Whether the accord satisfies the various stakeholders who have been demanding action on AI safety is another question.

For the industry, the answer may depend on how much pressure the companies were under to sign it. The agreement is voluntary and largely consists of measures that many of the leading AI companies already have in place. According to an article in the Washington Post, Dario Amodei himself characterized it as “a start,” while reporting indicates that the companies have been under increasing pressure as incidents involving AI agents going beyond their intended boundaries have multiplied. 

For consumer advocates and others who have been calling for meaningful government oversight, the accord may be viewed as insufficient. It does not establish enforceable standards, specify what constitutes an independent auditor, require public disclosure of audit findings, or provide a government enforcement mechanism. A recent Reuters/Ipsos poll found that 73% of respondents believed AI companies had not done enough to prevent AI from causing serious harm. 

Congress may similarly conclude that voluntary commitments are not enough. Interestingly, however, the accord expressly leaves the door open to legislation or regulation by stating that, “Over time, it may make sense to codify these steps into laws and regulations.” 

The timing also presents an unusual challenge for Anthropic. The company is moving toward what could be a landmark IPO at the same time that concerns about rogue frontier AI systems are receiving extraordinary attention. Anthropic’s IPO prospectus reportedly warns investors that increasingly advanced AI could create “catastrophic or existential risks to humanity” and that autonomous AI agents could create significant and unpredictable legal risks, including unauthorized financial transactions and data loss. 

That raises an obvious question: Can Anthropic successfully bring a frontier-AI company public while simultaneously telling prospective investors that its technology could pose existential risks and that the legal consequences of rogue AI behavior remain unsettled?

The answer will depend in substantial part on whether investors view the company’s safety and governance mechanisms as credible. The new accord gives Anthropic and the other participating companies an opportunity to demonstrate that they can subject their own safety controls to meaningful independent scrutiny. Whether that will be enough to satisfy investors, consumer advocates, Congress, and others who are demanding more rigorous safeguards remains to be seen.